JPMorgan Chase & Co. Reaffirms "Overweight" Rating for Shire PLC
's stock had its "overweight" rating restated by analysts at JPMorgan Chase & Co. in a note issued to investors on Monday.
from Biotech News
's stock had its "overweight" rating restated by analysts at JPMorgan Chase & Co. in a note issued to investors on Monday.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments